Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349)
Market Open
18 Aug, 08:00
HKEX 
2. 66
HKD -0.01
-0.5607%
- Market Cap
- P/E Ratio
0.09% Div Yield
240,000 Volume
0 Eps
2.67 HKD
Previous Close Want to track 1349 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349) Statistics
Valuation metrics
Market Cap -
Enterprise value -136.78M
Trailing P/E (ttm) -59.02
Forward P/E -
PEG ratio -1.63
Price/Sales (ttm) 1.5
Price/Book (mrq) 4.18
Enterprise Value/Revenue -0.21
Enterprise Value/EBITDA 1.73
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.43M
Average volume (90 days) 2.52M
Price summary
52-Week low 2.2
52-Week high 4.22
Beta -
50-Day moving average 2.44
200-Day moving average 2.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.05
Trailing annual dividend yield 0.0058%
5-Year annual dividend yield -
Payout ratio -0.2
Dividend Date 25 Aug 2025
Ex-Dividend Date 10 Jul 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.23%
Operating margin -0.26%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.09
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 7.46%
Book value per share (mrq) 2.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
